In this study, it was found that Liquiritin protects heart tissue against myocardial fibrosis following MI by inhibiting the expression of CCL5 (a pro-inflammatory chemokine) and the NF-κB pathway [63]. The gene discussed is NFKB1; the disease is Myocardial fibrosis.